AccessMyLibrary provides FREE access to over 30 million articles from top publications available through your library.
Create a link to this page
Copy and paste this link tag into your Web page or blog:
2003 AUG 13 - (NewsRx.com & NewsRx.net) -- Enhanced T-cell immunogenicity of plasmid DNA vaccines was boosted by recombinant modified vaccinia virus Ankara in humans.
According to published research from England and the United States, "In animals, effective immune responses against malignancies and against several infectious pathogens, including malaria, are mediated by T cells. Here we show that a heterologous prime-boost vaccination regime of DNA either intramuscularly or epidermally, followed by intradermal recombinant modified vaccinia virus Ankara (MVA), induces high frequencies of interferon (IFN)-gamma-secreting, antigen-specific T-cell responses in humans to a pre-erythrocytic malaria antigen, thrombospondin-related adhesion protein (TRAP)."
"These responses are 5- to 10-fold higher than the T-cell responses induced by the DNA vaccine or recombinant MVA vaccine alone, and produce partial protection manifest as delayed parasitemia after sporozoite challenge with a different strain of Plasmodium falciparum," reported Samuel J. McConkey and collaborators at the University of Oxford, ...
Source: HighBeam Research, Immunogenicity of DNA vaccines boosted by modified vaccinia virus...